ArticleFrontiers in nutrition2026

A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) study.

Maria Argente-Pla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.